Klünemann H H, Ridha B H, Magy L, Wherrett J R, Hemelsoet D M, Keen R W, De Bleecker J L, Rossor M N, Marienhagen J, Klein H E, Peltonen L, Paloneva J
Department of Psychiatry, University of Regensburg School of Medicine, Germany.
Neurology. 2005 May 10;64(9):1502-7. doi: 10.1212/01.WNL.0000160304.00003.CA.
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), or Nasu-Hakola disease, is a presenile dementia associated with loss of myelin, basal ganglia calcification, and bone cysts. It is caused by recessively inherited mutations in two genes encoding subunits of a cell membrane-associated receptor complex: TREM2 and DAP12. The clinical course of PLOSL has not been characterized in a series of patients with TREM2 mutations.
The authors compare neurologic and neuroradiologic follow-up data of six patients carrying TREM2 mutations with PLOSL due to defective DAP12 genes. The authors review the known mutations in these two genes.
Mutations in DAP12 and TREM2 result in a uniform disease phenotype. In Finnish and Japanese patients with PLOSL, DAP12 mutations predominate, whereas TREM2 is mutated more frequently elsewhere.
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy should be considered in adult patients under age 50 years with dementia and basal ganglia calcification. Radiographs of ankles and wrists, and DNA test in uncertain cases, confirm the diagnosis.
多囊性脂膜性骨发育异常伴硬化性白质脑病(PLOSL),即那须 - 哈科拉病,是一种早老性痴呆,与髓鞘丢失、基底节钙化和骨囊肿有关。它由编码细胞膜相关受体复合物亚基的两个基因的隐性遗传突变引起:触发受体表达于髓细胞2(TREM2)和DNAX激活蛋白12(DAP12)。PLOSL的临床病程尚未在一系列携带TREM2突变的患者中得到描述。
作者比较了6例因DAP12基因缺陷而患有PLOSL且携带TREM2突变的患者的神经学和神经放射学随访数据。作者回顾了这两个基因中的已知突变。
DAP12和TREM2的突变导致一致的疾病表型。在芬兰和日本患有PLOSL的患者中,DAP12突变占主导,而在其他地方TREM2突变更为频繁。
对于50岁以下患有痴呆和基底节钙化的成年患者,应考虑多囊性脂膜性骨发育异常伴硬化性白质脑病。踝关节和腕关节的X线片以及在不确定病例中的DNA检测可确诊。